Literature DB >> 27750392

The clinical, radiological, microbiological, and molecular profile of the skin-penetration site of transfemoral amputees treated with bone-anchored prostheses.

Maria Lennerås1,2, Georgios Tsikandylakis2,3, Margarita Trobos1,2, Omar Omar1,2, Forugh Vazirisani1,2, Anders Palmquist1,2, Örjan Berlin2,3,4, Rickard Brånemark2,3,4,5, Peter Thomsen1,2.   

Abstract

The breach of the skin barrier is a critical issue associated with the treatment of individuals with transfemoral amputation (TFA) using osseointegrated, percutaneous titanium implants. Thirty TFA patients scheduled for abutment exchange or removal were consecutively enrolled. The aims were to determine the macroscopic skin signs, the presence of bacteria and the gene expression in abutment-adherent cells and to conduct correlative and comparative analyses between the different parameters. Redness and a granulation ring were present in 47% of the patients. Bacteria were detected in 27/30 patients, commonly in the bone canal. Staphylococcus aureus, coagulase-negative staphylococci, streptococci, and Enterococcus faecalis were the most common. A positive correlation was found between TNF-α expression and the detection of S. aureus. Staphylococcus aureus together with other bacterial species revealed a positive relationship with MMP-8 expression. A negative correlation was demonstrated between the length of the residual femur bone and the detection of a granulation ring and E. faecalis. A positive correlation was revealed between fixture loosening and pain and the radiological detection of endosteal bone resorption. Fixture loosening was also correlated with the reduced expression of interleukin-10 and osteocalcin. It is concluded that several relationships exist between clinical, radiological, microbiological, and molecular assessments of the percutaneous area of TFAs. Further long term studies on larger patient cohorts are required to determine the precise cause-effect relationships and unravel the role of host-bacteria interactions in the skin, bone canal and on the abutment for the longevity of percutaneous implants as treatment of TFA.
© 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 578-589, 2017. © 2016 The Authors Journal of Biomedical Materials Research Part A Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  gene expression; infection; osseointegration; percutaneous; transfemoral amputees

Mesh:

Substances:

Year:  2016        PMID: 27750392      PMCID: PMC5216444          DOI: 10.1002/jbm.a.35935

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


INTRODUCTION

Clinical1, 2, 3, 4 and experimental5 studies suggest that a percutaneous, osseointegrated prosthesis is an interesting and promising alternative for the treatment of amputees. During the past 20 years, a new method for the rehabilitation of individuals with transfemoral amputation (TFA) has evolved. Instead of suspension through a socket, the prosthetic leg is directly anchored to the residual femur by an osseointegrated, percutaneous implant.6 The implant consists of a titanium screw called the “fixture”, an extension called the “abutment” and an abutment screw that keeps the two components together. The fixture is implanted in the medullary cavity in first‐stage surgery (S1), while the abutment, which is inserted in‐second stage surgery (S2), usually 6 months later, penetrates the skin through the skin‐penetration site (SPS). A similar concept is used for the direct anchorage of dental implants in the jaw7 and hearing aids in the temporal bone8 before its implementation in transfemoral and arm amputees.9 The direct skeletal anchorage of the prosthetic leg results in an enhanced quality of life, improved function and fewer out‐patient visits for the adjustment of the prosthesis compared with socket prostheses.1, 10 Since roentgen stereo photogrammetric analysis (RSA) of fixtures in TFAs have indicated the stable fixation of the fixture in the residual bone,11 the scientific interest has converged on the SPS, where an interface of titanium, bone, and soft tissue comes into contact with the outer environment. There is growing evidence that periprosthetic orthopedic infections have a biofilm origin, are frequently subclinical and culture negative, making the diagnosis and treatment challenging.12 Although only a few infections leading to fixture removal have occurred13 in arm and leg amputees and the fixture has demonstrated a survival rate of 92% at 2 years9 in transfemoral amputees, it can be expected that a percutaneous implant is at great risk and will become infected and fail. Our knowledge of the bacteriological profile of the SPS is still limited. Moreover, there is an absence of information on the biological mediators, for example, pro‐ and anti‐inflammatory cytokines and markers of cell differentiation and matrix remodeling,14, 15, 16 contributing to inflammation and repair of the tissues which interface the material components in the SPS. The aims of this study of TFAs with bone‐anchored amputation prostheses are first, to determine the frequency of macroscopic signs of inflammation in the SPS, to determine which bacteria are resident in the SPS, abutment and surrounding bone canal and to analyze the gene expression of inflammatory, bone, and soft‐tissue markers in abutment‐adherent cells and, secondly, to conduct correlative and comparative analyses between clinical signs, radiological findings, gene expressions, and the presence of different bacterial species.

MATERIALS AND METHODS

Implants and abutments

The materials used in this study are commercially available components (Integrum AB, Mölndal, Sweden) [Fig. 1(A,B)]. The fixture is made of commercially pure titanium (cp‐Ti), the abutment screw of Ti6Al4V and the abutment of cp‐Ti or Ti6Al4V. The topography, oxide thickness, morphology and crystallinity of the implants has been described elsewhere.17 The surface morphology of the abutment was characterized by scanning electron microscopy and interference microscopy (Supporting Information Fig. 1).
Figure 1

An overview of the implant components, the sampling procedures and the clinical assessment of the skin. (A, B) Schematic drawing showing the implant components and surrounding tissue. Abutments with a diameter of 11 mm and a length of 72–77 mm were machined from cp‐Ti grade IV (n = 29) and titanium alloy (Ti6Al4V, grade V) (n = 1), cleaned by ultrasonication followed by sterilisation. (C‐E) Bacterial swabs taken from skin‐penetration site (C), abutment (D) and bone canal (E). (F, G) Retrieval of abutment for macroscopic inspection (F) and placement in a fixed volume of RNAlater (G) for subsequent RNA and protein extraction. (H‐K) Representative skin‐penetration sites for the scoring system: H) Score 0: clean, dry, tight; I) Score 2: purple, serous secretion; J) Score 3: granulation ring, redness; K) Score 4: granulation ring, redness, serous secretion.

An overview of the implant components, the sampling procedures and the clinical assessment of the skin. (A, B) Schematic drawing showing the implant components and surrounding tissue. Abutments with a diameter of 11 mm and a length of 72–77 mm were machined from cp‐Ti grade IV (n = 29) and titanium alloy (Ti6Al4V, grade V) (n = 1), cleaned by ultrasonication followed by sterilisation. (C‐E) Bacterial swabs taken from skin‐penetration site (C), abutment (D) and bone canal (E). (F, G) Retrieval of abutment for macroscopic inspection (F) and placement in a fixed volume of RNAlater (G) for subsequent RNA and protein extraction. (H‐K) Representative skin‐penetration sites for the scoring system: H) Score 0: clean, dry, tight; I) Score 2: purple, serous secretion; J) Score 3: granulation ring, redness; K) Score 4: granulation ring, redness, serous secretion.

Clinical data

Study design and patient demographics

This study was conducted as a cross‐sectional uncontrolled study. During a 2‐year period, 30 consecutive TFA patients with a percutaneous, osseointegrated implant who had to exchange (26 patients) or remove (4 patients) their abutment were enrolled. Patient data is found in Table 1. Two of the thirty patients were bilateral femoral amputees treated on both sides with the implant system. In one of these patients, the abutment on one side was exchanged. In the other patient, both abutments were exchanged and one side was randomly selected to be included in the study. A total of 30 abutments in 30 patients were therefore included in the study. The reason for abutment exchange was mechanical problems (26 patients) of the abutments (i.e. wear, bending, cracking, or fracture of the abutment). One of these patients (ID 6) received flucloxacillin (1 g x 3) due to a culture verified superficial infection of the SPS. Three patients (ID 4, 12 and 15) were diagnosed with fixture loosening and had their complete implant system removed. One of the three latter patients (ID 4) had completed a course of antibiotics within two weeks prior to implant removal due to a superficial infection of the SPS. One patient (ID 5) had the abutment removed and the SPS closed (leaving only the fixture in place) because of hyperesthesia, phantom pain and pain upon loading.
Table 1

Demographic Data on 30 Patients with TFA and Osseointegrated Bone‐Anchored Amputation Prostheses Undergoing Exchange or Removal of Their Abutments

VariablePopulationMean (SD)Median (min; max)
Patients30
Unilateral28
Bilateral2
Gender (male/female)24/6
Age at abutment exchange (years)51 (13)53 (25; 76)
Time since first surgery (S1) (years)6.6 (3.8)5 (0.6; 16)
Time since last exchange of abutment (years)4.4 (3.1)3 (2; 13)
Estimated weight at inclusion (S1) (kg)77 (18)76 (48; 116)
Demographic Data on 30 Patients with TFA and Osseointegrated Bone‐Anchored Amputation Prostheses Undergoing Exchange or Removal of Their Abutments

Observations and sampling at abutment exchange or removal

The abutment exchange or removal was performed in the operating theatre under sterile conditions. The SPS and the visible part of the abutment protruding through the skin (distal of the bone canal) were washed with clorhexidine solution. After obtaining a swab for microbiology from the SPS [Fig. 1(C)], the abutment was removed [Fig. 1(F)]. A second swab was taken from the surface of the part of the abutment that had been located inside the bone canal [Fig. 1(D)]. The removed abutment was then placed in a tube containing RNAlater Stabilisation Reagent (Qiagen, Germany) [Fig. 1(G)] for the subsequent extraction of RNA and protein. Only the part of the abutment that was inside the bone canal was covered by RNAlater. Next, a third swab was obtained from the surface of the tissue in the canal between the distal bone and the abutment, here called bone canal [Fig. 1(E)]. The clinical appearance of the SPS was documented by photography and macroscopically observed clinical signs were documented by one observer. Using a modification of the so‐called Holgers scoring system18 for the assessment of soft tissue around bone‐anchored hearing aids, a modified classification system was implemented [Fig. 1(H‐K), Table 2]. The symptoms (e.g. pain) from the stump were also recorded. Moreover, the length of the residual femur (top of the trochanter major to distal femur) was recorded using radiographs. The most recent plain radiographs of the residual femur at the time of abutment exchange were examined and compared with the postoperative (S2) plain X‐ray examination. The radiographs were examined qualitatively by one observer for signs of bone remodeling around the fixture (Fig. 2).11 The mean time interval between the latest plain X‐ray and the time of abutment exchange was 5.8 (SD 7.4) months. The study protocol was approved by the Regional Ethical Review Board of Gothenburg (Dnr 110–14; 2014–03‐27). All subjects enrolled have responded to an Informed Consent which has been approved by the Ethical Review Board. The protocol was found acceptable and signed by them.
Table 2

Modified Holgers Scoring System With Values Ranging From 0 to 6 Depending on the Appearance of the Skin‐Penetration Site (SPS)

Inspection
Skin colorNormal0
Purple1
Red2
Moistness/secretionNo0
Serous1
Purulent2
GranulationNo0
Yes1
FistulasNo0
Yes1
Sum  0 ‐ 6
Figure 2

Radiological changes (A‐F). (A) The early (after 3 years) postoperative X‐ray from patient 1 (P1). (B) The corresponding X‐ray at the 10‐year post‐operative follow‐up of P1. Proximal trabecular buttressing (an increase of the bone density at the proximal end of the fixture) (thick, black arrow) and cancellisation (an increase in the porosity of the cortex surrounding the fixture) (thin, black arrow) have developed. (C) The early postoperative X‐ray (after the first surgery, S1) from patient 2 (P2). (D) At two‐years, a cortical thinning (a decrease in the width of the cortex around the fixture) (white arrow‐head) is evident. (E) An early postoperative X‐ray from patient 3 (P3) after the second surgery, S2. (F). The X‐ray from patient 3 after seven years, demonstrates endosteal bone resorption (thin, white arrow) and distal bone resorption (thick, white arrow). Endosteal bone resorption is the resorption of endosteal bone around the threads of the fixture, while distal bone resorption is the resorption of the bone at the distal end of the fixture.

Radiological changes (A‐F). (A) The early (after 3 years) postoperative X‐ray from patient 1 (P1). (B) The corresponding X‐ray at the 10‐year post‐operative follow‐up of P1. Proximal trabecular buttressing (an increase of the bone density at the proximal end of the fixture) (thick, black arrow) and cancellisation (an increase in the porosity of the cortex surrounding the fixture) (thin, black arrow) have developed. (C) The early postoperative X‐ray (after the first surgery, S1) from patient 2 (P2). (D) At two‐years, a cortical thinning (a decrease in the width of the cortex around the fixture) (white arrow‐head) is evident. (E) An early postoperative X‐ray from patient 3 (P3) after the second surgery, S2. (F). The X‐ray from patient 3 after seven years, demonstrates endosteal bone resorption (thin, white arrow) and distal bone resorption (thick, white arrow). Endosteal bone resorption is the resorption of endosteal bone around the threads of the fixture, while distal bone resorption is the resorption of the bone at the distal end of the fixture. Modified Holgers Scoring System With Values Ranging From 0 to 6 Depending on the Appearance of the Skin‐Penetration Site (SPS)

Molecular analyses

RNA and protein isolation from cells adherent to the abutment

The retrieved abutment was transported in a vertical position and kept at 4°C until further analysis. The cells adhering to the surface of retrieved abutments in the bone canal were homogenised by RP1 lysis buffer and rough vortexing for three minutes. Total RNA and protein were extracted using a NucleoSpin RNA/protein kit (Macherey‐Nagel, Germany).

Quantitative polymerase chain reaction (qPCR)

Total RNA was normalised to 20 ng/µl before transcribed to cDNA. Primer design was performed using Primer Blast (http://www.ncbi.nlm.nih.gov/tools/primer-blast). The sequences are available at TATAA Biocenter AB, Gothenburg, Sweden. The following gene panel was used: calcitonin receptor (CR), cathepsin K (CatK), osteocalcin (OC), osteopontin (OPN) and Runx2 (bone markers); keratin (KRT6A), collagen I (Coll1a1) and collagen IV (Coll4a1), (soft‐tissue markers); tumour necrosis factor alpha (TNF‐α), interleukin‐6 (IL‐6), interleukin‐10 (IL‐10), interleukin‐1 beta (IL‐1β), matrix metalloproteinase‐8 (MMP‐8), tissue inhibitor of matrix metalloproteinase‐1 (TIMP‐1) and leukocyte esterase (ELA2) (markers of inflammation, matrix‐degrading enzymes and inhibitor). Quantities of target genes were normalized using the mean of the reference genes 18S ribosomal RNA (18S), glyceraldehyde 3‐phosphate dehydrogenase (GAPDH) and tyrosine 3‐monooxygenase/tryptophan 5‐monooxygenase activation protein, zeta (YWHAZ). The normalized relative quantities were calculated using the delta‐delta Cq method and assuming 90% PCR efficiency (k*1.9ΔΔCq).19 The qPCR analysis was performed with a TATAA SYBR GrandMaster Mix (TATAA Biocenter AB) in 10 μL reactions on the CFX96 platform (Bio‐Rad Laboratories, CA). The qPCR procedure was performed in accordance with the Minimum Information for Publication of Quantitative Real‐Time PCR Experiments (MIQE) guidelines.20

Western blot

The protein concentration of the abutment adherent cells was determined using a Pierce®BCA protein assay kit (Thermo Fisher Scientific, USA). Equal amounts of proteins (100 µg) were loaded per well separated on a 10% Mini‐Protean®TGX Precast Gel (Bio‐Rad Laboratories, CA) and transferred to nitrocellulose membranes (Bio‐Rad Laboratories). To prevent nonspecific binding, membranes were blocked with 2% nonfat milk powder in 1x Tris‐buffered saline (TBS)‐Tween at room temperature (RT) for 1.5 h. The membranes were incubated at RT for 1 h with HRP‐conjugated protein A antibody (Abcam, Cambridge, UK), diluted 1:2500 in 2% nonfat milk powder in TBSTween. The membranes were washed 3 × 20 min and finally developed using an Immun‐Star™WesternC™ chemiluminescence detection kit (Bio‐Rad Laboratories), according to the instructions of the manufacturer. Digital detection was performed using the ChemiDoc XRS+ system with Image Lab Software (Bio‐Rad Laboratories). The specificity of the antibody was confirmed in blot experiments using S. aureus (ATCC 25923) (positive control) and S. epidermidis (ATCC 35984) (negative control) derived extracellular vesicles.

Bacterial cultures

Samples were taken for bacterial cultures with a sterile cotton swab, transported in a coal‐based medium and cultured on general purpose and selective media according to a routine procedure at Sahlgrenska University Hospital (Clinical Microbiology Lab, Sahlgrenska University Hospital, Gothenburg, Sweden). Briefly, swabs were streaked on five different agar plates: Columbia horse blood (incubated under aerobic and anaerobic conditions), Grand Lux (GL) plate (5% CO2), Streptococcus plate (5% CO2), chromogenic Staphylococcus plate and Drigalski plate, following incubation at 37°C for two to six days. A tube containing thioglycollate medium was inoculated with each swab for enrichment, in order to increase the detection, and incubated for six days at 37°C. All cultures were examined by experienced bacteriological analysts and the susceptibility of the clinical isolates to several antimicrobial agents was evaluated using the disk diffusion method. Further identification to species level was performed by MALDI‐TOF mass spectrometry.

STATISTICS

For descriptive purposes the mean, standard deviation (SD), median, maximum, and minimum values are presented. The gene expression data were tested for normality, which revealed a general non‐normal distribution for all analyzed genes. For this reason, nonparametric tests were considered for the correlational and comparative analyses. A Spearman correlation analysis was performed between the different continuous and categorical (ordinal or nominal) variables. All variables entered in the correlation analysis and the numbers of patients (n) under each variable are described in Supporting Information Table 1. Correlations of nominal variables were excluded if the number of observations within a variable was fewer than 3. Based on the correlation, variables that showed significant correlations with gene expression were further compared with respect to the gene expression of the different biological factors analysed in the study. Statistical analyses were performed using SPSS software (SPSS Statistics, v.15, IBM Corporation) and p‐values of <0.05 were considered significant.

RESULTS

Surface analysis

A typical machined surface morphology was revealed by scanning electron microscopy, with scratches and ridges along the machining direction (Supporting Information Fig. 1). A homogenous surface structure was observed along the length of the abutment, with slightly smoother surface structure on flat surfaces, that is the hexagon and the square head. The smooth surface roughness was confirmed by the measurements of Sa 313 nm.

Clinical symptoms and macroscopic signs

Pain upon loading was experienced by 8/30 patients, whereas 3/30 patients experienced pain at rest. The most common clinical sign observed in the SPS was redness and a granulation ring, followed by purpleness and serous discharge (Table 3). The most frequent modified Holgers score was 2 (on a scale of 0 to 6) with 30% (9/30) of the SPSs having a score of 2 and 67% (20/30) a score of 2 or lower (Table 4). Three of the 30 patients scheduled for abutment change had symptoms and macroscopic signs indicating fixture loosening and underwent removal of the entire implant system. The detailed description of these patients is found in Supporting Information. The clinical, radiological, and bacteriological analyses related to these three patients are provided in Supporting Information Table 2.
Table 3

Clinical Signs of the Skin‐Penetration Site (SPS) and Their Frequency

Clinical signNo of patients (Frequency)Percentage (%)*
Normal skin color723
Purpleness930
Redness1447
Serous secretion517
Purulent secretion310
Granulation ring1447
Fistulas00

*n = 30.

Table 4

Modified Holgers Score

Modified Holgers scoreNo of patients
04
17
29
35
43
52
60
Total30
Clinical Signs of the Skin‐Penetration Site (SPS) and Their Frequency *n = 30. Modified Holgers Score

Radiology

The most common radiological change in the bone around the fixture was proximal trabecular buttressing (14 patients), followed by endosteal bone resorption (10 patients), cancellisation (2 patients) and cortical thinning (1 patient) (Table 5).
Table 5

Radiological Changes

Radiological changes since S2No of patients (Frequency)Percentage (%)*
Unchanged1033
Endosteal bone resorption1033
Distal bone resorption00
Cancellisation27
Cortical thinning13
Proximal trabecular buttressing1447

*n = 30.

Radiological Changes *n = 30.

Gene expression

The sampling and extraction of RNA from cells adhering to the abutment was successfully performed. The sampling procedure provided good RNA quality and detectable values for all selected genes with the exception of calcitonin receptor.

Bacteriology

Positive bacterial cultures from routine microbiological procedures from at least one site were found in 27/30 patients. The most commonly found bacterial species were Staphylococcus aureus (14 patients; 47%), followed by streptococci (7 patients), Enterococcus faecalis (6 patients), coagulase‐negative staphylococci (CoNS) (5 patients, including Staphylococcus lugdunensis) followed by a large range of different bacterial species (Table 6). The majority of positive bacterial cultures were obtained from the bone canal (40 positive cultures in 26 patients). Western Blot analysis of protein A on abutments demonstrated that 28 out of 30 abutments were positive for the protein (Figure 3). The two patients who did not show detection of protein A presented negative cultures, irrespective of sampling sites.
Table 6

Bacterial Species Found Post Chlorhexidine Exposure at the Skin‐Penetration Site (SPS), Abutment and Bone Canal of Patients (n = 30)

BacteriaNumber of patients (%)SPSAbutmentBone canal
Staphylococcus aureus 14 (47%)7513
Coagulase‐negative staphylococci (CoNS)3 (10%)013
Staphylococcus lugdunensis 2 (7%)002
Group B Streptococcus (GBS)4 (13%)114
Group G Streptococcus (GGS)1 (3%)011
Group A Streptococcus (GAS)1 (3%)101
Alpha‐haemolytic streptococci1 (3%)001
Enterococcus faecalis 6 (20%)006
Enterobacter spp.1 (3%)011
Corynebacterium simulans 1 (3%)111
Propionibacterium acnes 1 (3%)001
Morganella spp.1 (3%)001
Haemophilus parainfluenzae 1 (3%)001
Prevotella spp.1 (3%)001
Anaerobic mixed flora2 (7%)002
Gram‐positive skin flora2 (7%)111
No growth3 (10%)000
Total number of positive cultures11*# 11*# 40*#

*Several patients displayed the growth of ≥ 2 bacterial species at the same site. #Several patients displayed the growth of bacteria in more than one compartment.

Figure 3

Western blot analysis of protein A on the abutment. Examples of positive and negative Staphylococcus aureus protein A detection on abutment. P1: One patient of two who did not demonstrate positive detection of protein A. P2‐P4: Four patients (P2‐P4) with positive bands of Staphylococcus aureus protein A (≈50 kDa) detected in 28/30 patients.

Western blot analysis of protein A on the abutment. Examples of positive and negative Staphylococcus aureus protein A detection on abutment. P1: One patient of two who did not demonstrate positive detection of protein A. P2‐P4: Four patients (P2‐P4) with positive bands of Staphylococcus aureus protein A (≈50 kDa) detected in 28/30 patients. Bacterial Species Found Post Chlorhexidine Exposure at the Skin‐Penetration Site (SPS), Abutment and Bone Canal of Patients (n = 30) *Several patients displayed the growth of ≥ 2 bacterial species at the same site. #Several patients displayed the growth of bacteria in more than one compartment.

Correlation analyses

Several correlations between genes were revealed (Table 7). A positive relationship was demonstrated between inflammatory cytokine genes (TNF‐α, IL‐1β and IL‐6). Furthermore, all analysed inflammatory cytokines revealed a positive correlation with TIMP‐1. In addition, both inflammatory cytokines TNF‐α and IL‐6 showed positive correlations with ELA2. Also, a positive relationship was found between factors denoting tissue regeneration (Runx2 with Coll1a1 and Coll1a1with Coll4a1). Positive correlations were also found between factors denoting tissue regeneration and factors denoting tissue degradation and remodeling, such as Coll1a1 with CatK, OPN with CatK, OPN with MMP‐8 and Runx2 with ELA2. A relationship was also detected between tissue degradation and remodelling factors (CatK and MMP‐8). On the other hand, negative correlations were shown for the inflammatory cytokines (TNF‐α and IL‐1β) with tissue regeneration genes (Coll1a1 and Coll4a1).
Table 7

Correlation Analysis of Genes Expressed in the Abutment‐Adherent Cells

Positive correlationsNegative correlations
Genes(r)(p)Genes(r)(p)
TNF‐α/IL‐1β0.85<0.01TNF‐α/OPN−0.426<0.05
TNF‐α/IL‐60.731<0.01IL‐1β/OPN−0.46<0.05
TNF‐α/TIMP‐10.487<0.01IL‐1β/Coll1a1−0.39<0.05
TNF‐α/ELA‐20.365<0.05IL‐1β/Coll4a1−0.378<0.05
IL‐1β/IL‐60.721<0.01IL‐1β/CatK−0.547<0.01
IL‐1β/TIMP‐10.543<0.01
IL‐6/Runx20.452<0.05
IL‐6/TIMP‐10.467<0.01
IL‐6/ELA20.446<0.05
Coll1a1/Runx20.438<0.05
Coll1a1/Coll4a10.777<0.01
Coll1a1/CatK0.501<0.01
OPN/CatK0.634<0.01
OPN/MMP80.492<0.01
Runx2/KRT6A0.369<0.05
Runx2/ELA20.474<0.01
CatK/Coll4a10.411<0.05
CatK/MMP80.622<0.01
IL‐10/ELA20.568<0.01

The data show genes that revealed significant positive or negative relationships. Spearman correlation coefficients (r) and level of significance (p) are presented.

Correlation Analysis of Genes Expressed in the Abutment‐Adherent Cells The data show genes that revealed significant positive or negative relationships. Spearman correlation coefficients (r) and level of significance (p) are presented. When correlating the clinical parameters with gene expression activities (Table 8), a significant negative correlation was found for the loosened fixtures with the expression levels of the bone related gene OC and the anti‐inflammatory gene IL‐10. Furthermore, a negative relationship was found between the time span since the S1 or placement of the abutment with the expression of OPN, Coll1a1, or Coll4a1.
Table 8

Correlation Analysis Between Clinical Parametersa and Genes Expressed in the Abutment‐Adherent Cells

Clinical ParametersCorrelated Genes(r)(p)
Time since S1 surgery (fixture installation)OPN−0.413<0.05
Coll4a1−0.378<0.05
Time since last abutment installationColl4a1−0.521<0.01
Fixture looseningOC−0.430<0.05
IL‐10−0.404<0.05
Length of residual femur boneOC−0.398<0.05

No significant correlations were detected for other clinical parameters with any of the analyzed genes.

The data show genes that revealed significant correlations with clinical parameters. Spearman correlation coefficients (r) and level of significance (p) are presented.

Correlation Analysis Between Clinical Parametersa and Genes Expressed in the Abutment‐Adherent Cells No significant correlations were detected for other clinical parameters with any of the analyzed genes. The data show genes that revealed significant correlations with clinical parameters. Spearman correlation coefficients (r) and level of significance (p) are presented. When the correlation was performed between the different clinical parameters (Table 9), a positive relationship was shown between the loosened fixtures and the radiological detection of endosteal bone resorption. Moreover, a positive association was found between the fixture loosening and the reported pain symptom. The length of the residual femur bone demonstrated a negative correlation with the detection of granulation ring around the abutment.
Table 9

Correlation Analysis of Clinical Parametersa

Positive correlationsNegative correlations
(r)(p)(r)(p)
Fixture loosening/Endosteal bone resorption0.471<0.01Time since S1 surgery (fixture installation)/Fixture loosening−0.392<0.05
Fixture loosening/Pain symptom0.438<0.05Time since S1 surgery/Pain symptom−0.412<0.05
Skin color/Pain symptom0.392<0.05Length of residual femur bone/Granulation ring−0.479<0.01

No significant correlations were detected for the other clinical parameters.

The data show clinical parameters that revealed significant positive or negative relationships. Spearman correlation coefficients (r) and level of significance (p) are presented.

Correlation Analysis of Clinical Parametersa No significant correlations were detected for the other clinical parameters. The data show clinical parameters that revealed significant positive or negative relationships. Spearman correlation coefficients (r) and level of significance (p) are presented. With respect to bacterial colonisation (Table 10), the analysis revealed that the detection of bacteria (irrespective of which species) at the SPS was positively correlated to the time span since the last abutment installation, as well as with the detection of secretion around the abutment, whereas the detection of bacteria in the canal was only positively correlated to the time span since S1 surgery. In addition, the detection of Enterococcus faecalis (irrespective of site) was positively correlated to the presence of granulation tissue. A negative correlation was shown between the length of femur bone and the detection of E. faecalis.
Table 10

Correlation of Bacterial and Clinical Parametersa

Bacterial findingsCorrelated clinical parameters(r)(p)
Detection of any bacterial species at SPSTime since last abutment installation0.467<0.01
Secretion0.428<0.05
Detection of any bacterial species on the abutmentLength of residual femur bone0.399<0.05
Detection of any bacterial species in the bone canalTime since S1 surgery (fixture installation)0.431<0.05
Detection of Enterococcus faecalis irrespective of siteLength of residual femur bone−0.398<0.05
Detection of Enterococcus faecalis irrespective of siteGranulation ring0.367<0.05

No significant correlations were detected for other clinical parameters with any of the analysed bacterial findings.

The data show clinical parameters that revealed significant correlations with bacterial findings. Spearman correlation coefficients (r) and level of significance (p) are presented.

Correlation of Bacterial and Clinical Parametersa No significant correlations were detected for other clinical parameters with any of the analysed bacterial findings. The data show clinical parameters that revealed significant correlations with bacterial findings. Spearman correlation coefficients (r) and level of significance (p) are presented. The correlation between bacteria and gene expression (Table 11) revealed a positive correlation between the expression of TNF‐α and the detection of S. aureus irrespective of site. Moreover, the detection of S. aureus together with any other bacterial species showed a positive relationship with the expression of MMP‐8. A detection of a polymicrobial flora at the different sites was positively correlated to Runx2, IL‐6 and MMP‐8.
Table 11

Correlation of Bacteria and Genesa Expressed in the Abutment‐Adherent Cells

Bacterial findingsCorrelated genes(r)(p)
Detection of S. aureus irrespective of siteTNF‐α0.394<0.05
Detection of coagulase‐negative staphylococci irrespective of siteOPN0.392<0.05
Detection of S. aureus with other bacterial species irrespective of siteMMP‐80.531<0.01
Detection of polymicrobial floraRunx20.400<0.05
IL‐60.423<0.05
MMP‐80.369<0.05

No significant correlations were detected for other genes with any of the analyzed bacterial findings..

The data show genes that revealed significant correlations with bacterial findings. Spearman correlation coefficients (r) and level of significance (p) are presented.

Correlation of Bacteria and Genesa Expressed in the Abutment‐Adherent Cells No significant correlations were detected for other genes with any of the analyzed bacterial findings.. The data show genes that revealed significant correlations with bacterial findings. Spearman correlation coefficients (r) and level of significance (p) are presented.

Comparative gene expression analyses

Based on the results of the correlation analysis, nominal bacterial or clinical variables that revealed significant correlations with gene expression were further evaluated by comparative analysis. When the subjects were divided into osseointegrated (n = 27) and loosened fixture (n = 3) groups, the comparative gene expression analysis revealed about a 3.5‐fold lower expression of the OC in the loosened fixture group compared with the osseointegrated one [Fig. 4(A)]. Furthermore, the loosened fixture group showed a seven‐fold lower expression of the anti‐inflammatory cytokine IL‐10 compared with the osseointegrated group [Fig. 4(B)]. When the patients were divided based on the detection (n = 14) or absence (n = 16) of S. aureus, a two‐fold higher expression of TNF‐α was registered in the group with viable S. aureus detected [Fig. 5(A)]. This was further verified when the patients were divided into three groups: no detection of viable S. aureus (n = 16); single detection of S. aureus (n = 6) and S. aureus detected with other bacteria (n = 8) [Fig. 5(B)]. Further, a higher expression of TNF‐α was found when S. aureus was detected alone in comparison with no detection of S. aureus. On the other hand, a 4.5‐ and 2‐fold higher expression of MMP‐8 was demonstrated for S. aureus with other bacteria compared with S. aureus detected alone and undetected, respectively [Fig. 5(C)].
Figure 4

Gene expression of (A) osteocalcin (OC) and (B) interleukin‐10 (IL‐10) in the abutment‐adherent cells. The comparison was performed between patients with osseointegrated fixtures (n = 27) and patients with loosened fixtures (n = 3). Bars indicate statistically significant differences (p < 0.05).

Figure 5

Gene expression of tumour necrosis factor‐alpha (TNF‐α) and matrix metalloproteinase‐8 (MMP‐8) in the abutment‐adherent cells. The comparative analyses were performed as following: (A) TNF‐α expression in patients in whom S. aureus was not detected (n = 16) versus patients in whom S. aureus was detected (n = 14); (B) TNF‐α expression in patients in whom S. aureus was not detected (n = 16) versus patients in whom S. aureus was detected alone (n = 6) or detected with other bacteria (n = 8); (C) MMP‐8 expression in patients in whom S. aureus was not detected (n = 16) versus patients in whom S. aureus was detected alone (n = 6) or detected with other bacteria (n = 8). The bars indicate statistically significant differences (p < 0.05).

Gene expression of (A) osteocalcin (OC) and (B) interleukin‐10 (IL‐10) in the abutment‐adherent cells. The comparison was performed between patients with osseointegrated fixtures (n = 27) and patients with loosened fixtures (n = 3). Bars indicate statistically significant differences (p < 0.05). Gene expression of tumour necrosis factor‐alpha (TNF‐α) and matrix metalloproteinase‐8 (MMP‐8) in the abutment‐adherent cells. The comparative analyses were performed as following: (A) TNF‐α expression in patients in whom S. aureus was not detected (n = 16) versus patients in whom S. aureus was detected (n = 14); (B) TNF‐α expression in patients in whom S. aureus was not detected (n = 16) versus patients in whom S. aureus was detected alone (n = 6) or detected with other bacteria (n = 8); (C) MMP‐8 expression in patients in whom S. aureus was not detected (n = 16) versus patients in whom S. aureus was detected alone (n = 6) or detected with other bacteria (n = 8). The bars indicate statistically significant differences (p < 0.05).

DISCUSSION

The permanent penetration of the skin by a nonbiological material represents a major clinical challenge. The breach of the skin barrier and the presence of the material create markedly different conditions compared with a normal skin.21 The most common clinical signs observed in the SPS in thirty consecutively observed patients were redness and the presence of a granulation ring. A modification of a commonly used scoring system for skin status around bone‐anchored hearing aids18 did not correlate with any clinical diagnosis, radiological, microbiological or proinflammatory markers. The problems most frequently reported by transfemoral amputees are heat/sweating in the prosthetic socket and sores/skin irritation.22 In a two‐year prospective follow‐up of uni‐lateral transfemoral amputees with this percutaneous bone‐anchored system, a considerable improvement in these socket‐related problems was observed.23 Nevertheless, in comparison with percutaneous, bone‐anchored hearing aids,18 a considerably higher frequency of macroscopic inflammatory signs was found in the skin around the percutaneous, bone‐anchored amputation prostheses. Several plausible factors may explain this difference. Firstly, there are distinct differences in anatomy and the mechanical forces imposed on the bone and soft tissue in the two regions. In amputees the implant is weight bearing and the SPS is more mobile during ambulation and therefore presumably more prone to inflammation. Secondly, after amputation, the skin of the stump is considered to be more fragile and prone to skin problems due to pre‐existing disease and surgical trauma.24 The stump skin of lower‐extremity amputees wearing artificial limbs and complying with satisfactory stump hygiene, harbors a bacterial flora that is considerably more abundant and polymicrobial than that of the contralateral leg.25 In the present study, the majority of the implants were colonised at the skin exit with various pathogenic bacteria, and variably but frequently along the abutment down into the bone canal. Twenty‐seven out of 30 patients had positive cultures of potentially pathogenic bacteria such as Staphylococcus aureus, CoNS, various groups of streptococci, Enterococcus faecalis and Enterobacter. However, only one patient had a clinical manifestation of infection at the SPS, septic loosening of the fixture and a definite diagnosis of deep infection at the time of observation. The present bacterial findings are in general agreement with the results of a prospective, bacteriological study of both leg and arm amputees with osseointegrated prostheses.13 In the present study, the frequency of bacteria in the SPS may be underestimated due to the preoperative disinfection. The vast majority of the positive cultures in our study were derived from the bone canal. Although bacteria were detected in much lower frequency on the abutment compared with the bone canal, it is of importance that protein A, a surface protein in the cell wall of Staphylococcus aureus,26 was detected on the surface of abutments from 28/30 patients. The difference could reflect a lower sensitivity of swab sampling and culturing compared with Western blot. Further, Western blot might detect even the presence of dead staphylococci that presumably existed on the abutment because of the pre‐operative scrubbing of the SPS. The findings of viable bacteria and protein A on the abutment indicate that the bacteria are able to adhere to the surface of the titanium abutment, presumably via a surface coat of proteins and other cell debris. Since the property of forming biofilm constitutes an important virulence factor in bacteria, it is of great importance to determine whether the bacteria isolated from the abutment possess biofilm‐forming abilities. The skin has a great diversity of microorganisms that can potentially induce infection: first, via microbial invasion of the skin and subcutaneous tissues and, second, via the interaction with the host defense.27 In addition, the lower extremity has been found to be the most common location experiencing soft tissue infections.28 Although the present and previous observations13 suggest that the mere colonisation of the skin by bacteria is not equivalent to clinical manifestation of infection, the high frequency of bacterial colonisation indicates that the macroscopical inflammatory signs are associated with a high bacterial burden. Support for this assumption is that the presence of any bacteria in the skin and the presence of E. faecalis at any of the three sites were associated with skin secretion and a granulation ring, respectively. Moreover, the length of the femur of the amputated limb was positively correlated to the detection of any bacteria on the abutment and negatively correlated to the presence of E. faecalis. Since no significant improvements in maintaining residual limb hygiene were achieved two years after fitting with the osseointegrated, transcutaneous system,23 the present findings suggest the need of enforced and specific cleaning tools and instructions to patients. This is supported by the frequent detection of E. faecalis in the bone canal, and a positive Enterococcus spp. culture from one of the loosened fixtures. Moreover, enterococcal strains, isolated from implant‐associated osteomyelitis in the same type of patients, exhibited very high minimum biofilm eradication concentrations and none of the 10 tested antimicrobials was able to eradicate enterococcal biofilms.29 Taken together, the present findings underscore the necessity of future studies of the relationship between the bacterial species and the particular strain virulence, including biofilm properties and antimicrobial susceptibility when isolated from soft‐tissue sites and deep infections. Moreover, the search for antimicrobial strategies for the prevention and control of biomaterial‐associated infections has increased during the last years. However, only a few products are currently in clinical use, and device coating strategies are often tested and applied without taking into consideration each unique or specific clinical application.30 The present finding on the bacterial colonisation of percutaneous devices strongly highlights the need for alternative antimicrobial coatings, such as contact‐killing or anti‐adhesive surfaces, topical treatments, and cleaning regimens of the SPS that can help reduce the bacterial burden and entrance of potential pathogens into the bone site. A variety of radiological changes in the fixture‐bone interface up to 7 years post‐operatively have been described in transfemoral11 and transhumeral9 amputees. These changes are considered as signs of stress shielding similar to those observed in uncemented hip stems. Our results are consistent with previous radiologic studies with the exception of distal bone resorption which was not observed. The present findings support our assumption that endosteal bone resorption due to stress shielding or inflammation, with or without bacterial activity, could compromise the stability of the fixture. Although longer term studies are needed to understand the impact of endosteal bone resorption on fixture survival, this radiological finding could potentially increase the probability of fixture loosening in years to come. One important finding was the correlation between fixture loosening and reported pain as well as radiologically verified endosteal bone resorption. On the other hand, no association was found between endosteal bone resorption and bacteria in the SPS, on the abutment and in the bone canal. At present, pain upon loading, stump swelling and purulent secretion are regarded as important symptoms which, together with the results of microbiological cultures and radiologically verified osteolysis (i.e. bone resorption), constitute the criteria for deep infections.13 However, it is well known that amputees have a wide spectrum of pain sensations and the perception of different types of pain, not related to the actual transcutaneous prosthesis, does not appear to be improved after the two‐year follow‐up.23 An amputee may face serious effects to the prosthesis and the residual limb after e.g. a fall. The currently studied amputation system has been designed to cause a bending of the cp titanium abutment rather than fractures in the bone and/or breakage of the fixture. However, an optimisation of the material properties, biomechanics and antibacterial properties is foreseen. Although the need for exchange or removal of the abutment constituted the inclusion criterion in the present study, the mechanical complications were not the focus. Two‐year data from a prospective study reveals a complication rate of 8% (4/51 patients) leading to an exchange of the abutment and/or abutment screw.1 Our study has certain limitations. The 30 selected patients constituted a heterogeneous group with a spread in time since fixture installation and time since the last abutment exchange. The common feature in our cohort was the need for abutment exchange or removal, mainly due to the mechanical failure of the abutment. This represents a potential selection bias, as the study could not have been conducted on a randomly selected sample of transfemoral amputees. The bacterial sampling was performed after disinfecting the SPS, which is expected to have resulted in an under‐estimation of the bacterial colonisation. Moreover, there was a latency between X‐ray and abutment exchange. Additionally, the number of patients with loose fixture was low which makes it difficult to draw solid conclusions in relation to this group. Importantly, a correlation was found between fixture loosening and a lower expression of osteocalcin and IL‐10. IL‐10 is generally regarded as an anti‐inflammatory cytokine which is implicated in the control of the inflammatory response15 and a regulator of immunity to infection.31 IL‐10 also induces the expression of TIMPs and OPG, the respective inhibitors of MMPs and RANKL systems,32 hence implicated in preventing bone resorption. Myeloid‐derived suppressor cell secretion of IL‐10 promotes the development of macrophage anti‐inflammatory phenotype.33 Interestingly, a monocyte and macrophage proinflammatory gene expression and clearance of S. aureus was demonstrated in IL‐10 knock‐out mice,33 at least partly explained by inhibition of myeloid‐derived suppressor cells. Although a cause‐effect relationship has not been established, the present observation of S. aureus in high frequency in the bone canal was associated with an increased expression of TNF‐α and MMP‐8, suggesting a mounted inflammatory response in order to clear the bacteria. On the other hand, no correlation was detected between the presence of bacteria and IL‐10 expression. Albeit speculative, the multiple clinical signs of skin inflammation, an abundance of bacteria and an increased pro‐inflammatory gene expression provide a scenario, which may ultimately lead to a degradation of the bone holding the fixture. A prerequisite is that pro‐inflammatory/degradation signals and inflammatory cells would reach and migrate, respectively, to the actual fixture‐bone interface. Such process would be balanced by anti‐inflammatory activity and pro‐regenerative activities. Interestingly, this hypothesis is at least partly supported by the finding that the three patients with fixture loosening displayed a lower anti‐inflammatory IL‐10 and pro‐osteogenic OC gene expression in abutment‐adherent cells.

CONCLUDING REMARKS

The skin penetrating abutment of amputation prostheses was frequently colonized with pathogens and often independent from traditional clinical signs of infection. While bacteria were detected in 27/30 patients, only 10% of the implants required complete removal over the study interval. Collected correlations across observational, microbiological and radiographic results indicated that the confirmed presence of bacteria (i) increased the gene expression of markers involved in inflammation and (ii) prompted a potential shift of host bone homeostasis. Nearly half of the proximal femurs exhibited proximal buttressing in response to the osseointegrated implant. Endosteal bone resorption could be an alarming radiological sign regarding the fixation and future survival of the fixture especially when combined with pain at loading. The current prescribed daily abutment cleaning protocol, while considered adequate to this point to limit commensal bacterial load, may require revision or improved patient compliance. Supporting Information Click here for additional data file.
  33 in total

1.  The bacterial flora of the skin of amputation stumps.

Authors:  M F ALLENDE; G H BARNES; S W LEVY; W J O'REILLY
Journal:  J Invest Dermatol       Date:  1961-03       Impact factor: 8.551

2.  Socket versus bone-anchored trans-femoral prostheses: hip range of motion and sitting comfort.

Authors:  K Hagberg; E Häggström; M Uden; R Brånemark
Journal:  Prosthet Orthot Int       Date:  2005-08       Impact factor: 1.895

3.  Distribution of protein A on the surface of Staphylococcus aureus.

Authors:  Andrea C DeDent; Molly McAdow; Olaf Schneewind
Journal:  J Bacteriol       Date:  2007-04-06       Impact factor: 3.490

4.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

Authors:  Stephen A Bustin; Vladimir Benes; Jeremy A Garson; Jan Hellemans; Jim Huggett; Mikael Kubista; Reinhold Mueller; Tania Nolan; Michael W Pfaffl; Gregory L Shipley; Jo Vandesompele; Carl T Wittwer
Journal:  Clin Chem       Date:  2009-02-26       Impact factor: 8.327

5.  Biofilm formation and antimicrobial susceptibility of staphylococci and enterococci from osteomyelitis associated with percutaneous orthopaedic implants.

Authors:  Magdalena Zaborowska; Jonatan Tillander; Rickard Brånemark; Lars Hagberg; Peter Thomsen; Margarita Trobos
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2016-10-25       Impact factor: 3.368

6.  Osseointegrated titanium implants in the temporal bone. A clinical study on bone-anchored hearing aids.

Authors:  A Tjellström; J Lindström; O Hallén; T Albrektsson; P I Brånemark
Journal:  Am J Otol       Date:  1981-04

7.  Genetic susceptibility to total hip arthroplasty failure: a preliminary study on the influence of matrix metalloproteinase 1, interleukin 6 polymorphisms and vitamin D receptor.

Authors:  M H A Malik; F Jury; A Bayat; W E R Ollier; P R Kay
Journal:  Ann Rheum Dis       Date:  2007-03-15       Impact factor: 19.103

8.  Interleukin-10 production by myeloid-derived suppressor cells contributes to bacterial persistence during Staphylococcus aureus orthopedic biofilm infection.

Authors:  Cortney E Heim; Debbie Vidlak; Tammy Kielian
Journal:  J Leukoc Biol       Date:  2015-07-31       Impact factor: 4.962

9.  Implant survival, adverse events, and bone remodeling of osseointegrated percutaneous implants for transhumeral amputees.

Authors:  Georgios Tsikandylakis; Örjan Berlin; Rickard Brånemark
Journal:  Clin Orthop Relat Res       Date:  2014-10       Impact factor: 4.176

10.  The clinical, radiological, microbiological, and molecular profile of the skin-penetration site of transfemoral amputees treated with bone-anchored prostheses.

Authors:  Maria Lennerås; Georgios Tsikandylakis; Margarita Trobos; Omar Omar; Forugh Vazirisani; Anders Palmquist; Örjan Berlin; Rickard Brånemark; Peter Thomsen
Journal:  J Biomed Mater Res A       Date:  2016-11-07       Impact factor: 4.396

View more
  13 in total

Review 1.  [Transcutaneous osseointegrated prosthesis (TOP) after limb amputation : Status quo and perspectives].

Authors:  Christian Willy; Christian Krettek
Journal:  Unfallchirurg       Date:  2017-05       Impact factor: 1.000

Review 2.  [Transcutaneous osseointegrated prosthetic systems after major amputation of the lower extremity : A retrospective 3-year analysis].

Authors:  Marcus Örgel; Alexander Ranker; Afif Harb; Christian Krettek; Horst-Heinrich Aschoff
Journal:  Orthopade       Date:  2021-01       Impact factor: 1.087

3.  Loading Effect of Prosthetic Feet's Anthropomorphicity on Transtibial Osseointegrated Implant.

Authors:  Mark Pitkin; Laurent Frossard
Journal:  Mil Med       Date:  2021-01-25       Impact factor: 1.437

Review 4.  Biomechanical Characterisation of Bone-anchored Implant Systems for Amputation Limb Prostheses: A Systematic Review.

Authors:  Alexander Thesleff; Rickard Brånemark; Bo Håkansson; Max Ortiz-Catalan
Journal:  Ann Biomed Eng       Date:  2018-01-11       Impact factor: 3.934

5.  The clinical outcome and microbiological profile of bone-anchored hearing systems (BAHS) with different abutment topographies: a prospective pilot study.

Authors:  Margarita Trobos; Martin Lars Johansson; Sofia Jonhede; Hanna Peters; Maria Hoffman; Omar Omar; Peter Thomsen; Malou Hultcrantz
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-05       Impact factor: 2.503

6.  Cytokine expression profile in the bone-anchored hearing system: 12-week results from a prospective randomized, controlled study.

Authors:  Tim George Ate Calon; Joost van Tongeren; Omar Omar; Martin Lars Johansson; Robert-Jan Stokroos
Journal:  Clin Implant Dent Relat Res       Date:  2018-04-27       Impact factor: 3.932

7.  Extracellular Vesicles Influence the Growth and Adhesion of Staphylococcus epidermidis Under Antimicrobial Selective Pressure.

Authors:  Magdalena Zaborowska; Carles Taulé Flores; Forugh Vazirisani; Furqan A Shah; Peter Thomsen; Margarita Trobos
Journal:  Front Microbiol       Date:  2020-07-02       Impact factor: 5.640

8.  Three-year follow-up of changes of cortical bone thickness after implantation of Endo-Exo-Prosthesis (EEP) for transfemoral amputees.

Authors:  Marcus Örgel; Emmanouil Liodakis; Pratya Jaratjitwilai; Afif Harb; Nils Wirries; Mohamed Omar; Christian Krettek; Horst-Heinrich Aschoff
Journal:  J Orthop Surg Res       Date:  2020-05-04       Impact factor: 2.359

9.  The clinical, radiological, microbiological, and molecular profile of the skin-penetration site of transfemoral amputees treated with bone-anchored prostheses.

Authors:  Maria Lennerås; Georgios Tsikandylakis; Margarita Trobos; Omar Omar; Forugh Vazirisani; Anders Palmquist; Örjan Berlin; Rickard Brånemark; Peter Thomsen
Journal:  J Biomed Mater Res A       Date:  2016-11-07       Impact factor: 4.396

10.  Clinical Outcomes of Soft Tissue Preservation Surgery With Hydroxyapatite-Coated Abutments Compared to Traditional Percutaneous Bone Conduction Hearing Implant Surgery-A Pragmatic Multi-Center Randomized Controlled Trial.

Authors:  M van Hoof; S Wigren; J Ivarsson Blechert; M A Joore; D J M Mateijsen; S J H Bom; J Stalfors; Måns Eeg-Olofsson; O Deguine; A J M van der Rijt; M C Flynn; J Marco Algarra; R J Stokroos
Journal:  Front Surg       Date:  2020-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.